Discover the full insider trade history of 명인제약, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Market capitalisation: €1,005.9bn. The latest transaction was filed on 8 May 2026 — Purchase. Among the most active insiders: 이행명. The full history is openly available.